Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists

Pediatric Nephrology

Volumn 21, Issue 5, 2006, Pages 729-732

  Daïkha Dahmane, Farida ^a   Levy Beff, Evelyne ^a   Jugie, Myriam ^a   Lenclen, Richard ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

Author keywords

AT 1 receptor antagonists; Fetal kidney; Pregnancy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN POTASSIUM; RENIN INHIBITOR;

ADULT; ARTERY WALL; ARTICLE; AUTOPSY; CASE REPORT; DISEASE SEVERITY; DOSE RESPONSE; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS MALFORMATION; HUMAN; HUMAN TISSUE; JUXTAGLOMERULAR APPARATUS; KIDNEY DEVELOPMENT; KIDNEY INJURY; KIDNEY MALFORMATION; KIDNEY TUBULE DISORDER; MATERNAL HYPERTENSION; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; RENOVASCULAR DISEASE; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; DISEASES IN TWINS; FEMALE; FETAL DEATH; FETAL DISEASES; HUMANS; HYPERTENSION; KIDNEY; LOSARTAN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL INJURIES;

EID: 33646159291     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0070-1     Document Type: Article

References (28)

1. Bermann MA, Walsh MF, Sowers JR (1997) Angiotensin II biochemistry and physiology: Update on angiotensin II receptor blockers. Cardiovasc Drug Rev 15:75-100
2. Saji H, Yamanaka M, Hagiwara A, Ljiri R (2001) Losartan and fetal toxic effects. Lancet 357:63
3. Martinovic J, Benachi A, Laurent N, Daïkha-Dahmane F, Gubler MC (2001) Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 358:241-242
4. Hinchliffe SA, Sargent PH, Howard CV, Chan YF, Hutton JL, Van Velzen D (1992) "Medullary ray glomerular counting" as a method of assessment of human nephrogenesis. Pathol Res Pract 188:775-782
5. Spence SG, Allen HL, Cukierski MA, Manson JM, Robertson RT, Eydelloth RS (1995) Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology 51:367-382
6. Spence SG, Cukierski MA, Manson JM, Robertson RT, Eydelloth RS (1995) Evaluation of the reproductive and developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology 51:383-397
7. Mehta N, Modi N (1989) ACE inhibitors in pregnancy. Lancet 8:96-97
8. Knott PD, Thorpe SS, Lamont CAR (1989) Congenital renal dysgenesis possibly due to captopril. Lancet 25:451
9. Cunniff C, Jones KL, Philipson J, Benirschke K, Short S, Wujek J (1990) Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. Am J Obstet Gynecol 162:187-189
10. Shah MM, Sampogna V, Hiroyuki S, Bush KT, Nigam SK (2004) Branching morphogenesis and kidney disease. Development 131:1449-1462
11. Bush KT, Sakurai H, Steer DL, Leonard MO, Sampogna RV, Meyer TN, Schwesinger C, Qiao J, Nigam SK (2004) TGF-β superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud. Dev Biol 266:285-298
12. Wolf G (2002) Angiotensin II and tubular development. Nephrol Dial Transplant 17:48-51
13. Akil I, Inan S, Gurcu B, Nazikoglu A, Ozbilgin K, Muftuoglu S (2005) Histopathological and ultrastructural effects of losartan on embryonic rat kidney. Acta Histochem 107:291-300
14. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA (1994) Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45:485-492
15. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA (1995) Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269:F110-F115
16. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM (1995) Regulation of blood pressure by the type IA angiotensin II receptor gene. Proc Natl Acad Sci USA 92:3521-3525
17. Friberg P, Guron G, Sundelin B, Wickman A, Adams MA (1996) Neonatal ACE inhibition in the pig causes irreversible abnormalities in the kidney. J Hypertens 14 [Suppl 1]:S54
18. Nilsson A, Adams M, Guron G, Sundelin B, Friberg P (1996) Reduced ability to excrete an acute volume load after neonatal ACE inhibition in the rat. J Am Soc Nephrol 7:1586
19. Nagata M, Tanimoto K, Fukamizu A, Kon Sugiyama F, Yagami K, Urakami K, Watanabe T (1996) Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest 75:745-753
20. Gomez RA (1998) Role of angiotensin in renal vascular development. Kidney Int 54 [Suppl]:S12-S16
21. Sequeira Lopez MLS, Gomez RA (2004) The role of angiotensin II in kidney embryogenesis and kidney abnormalities. Curr Opin Nephrol Hypertens 13:117-122
22. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, Ichikawa I (1998) Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101:755-760
23. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan A, Fogo A, Inagami T, Hogan B, Ichikawa I (1995) Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96:2947-2954
24. Okubo S, Niimura F, Matsusaka T, Fogo A, Hogan B, Ichikawa I (1998) Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney Int 53:617-625
25. Freeburg PB, Abrahamson DR (2003) Hypoxia-inducible factors and kidney vascular development. J Am Soc Nephrol 14:2723-2730
26. Karihaloo A, Karumanchi SA, Cantley WL, Venkatesha S, Cantley LG, Kale S (2005) Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion. Mol Cell Biol 25:7441-7448
27. Kitamura S, Maeshima Y, Sugaya T, Sugiyama H, Yamasaki Y, Makino H (2003) Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells. Nephron Exp Nephrol 95:79-86
28. Sanchez-Lopez E, Lopez AF, Esteban V, Yagüe S, Egido J, Ruiz-Ortega M, Alvarez-Arroyo MV (2005) Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1a induction and redox mechanisms in the kidney. Antioxid Redox Signal 7:1275-1284